Stockreport

AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed

AIM ImmunoTech Inc.  (AIM) 
PDF Incumbent Board’s Claims of Progress Are Not Credible or Supported by DataAIM Maintains Relationship with CRO Co-Founded by a Convicted Felon Who Deceived Investors abou [Read more]